Abstract
Polyunsaturated Fatty acids (PUFAs) seem to be helpful in the therapy of depression. Zinc (Zn) may be one co-factor contributing to their antidepressive effect. Zn acts lipid protective and is a constituent of fatty acid metabolism enzymes. In animals, an antidepressive effect of Zn was already demonstrated. Therefore, if and how Zn and PUFAs correlate in depressive patients or in individuals from the general population was investigated. Blood samples were collected from 88 depressive in-patients and 88 volunteers from the general population matched for age-group and gender (each 32 men and 56 women, 21–70 years) for measurement of Zn (colorimetric) and of 12 fatty acids (FAs) (by capillary gas-chromatography). Severity of depression in patients was assessed by Beck Depression Inventory (BDI) and Hamilton Depression Rating Scale (HDRS). Zn concentration was independent of age, gender and body-mass-index and significantly correlated with the severity of depression measured by BDI (r = 0.26; P = 0.034) in depressive patients,. HDRS was inversely correlated with gammalinolenic acid concentration (r = −0.24; P = 0.029). Median serum Zn concentration in depressive patients did not differ from control individuals. Zn was correlated with myristic acid concentration (r = 0.22; P < 0.05) in controls from the general population; and a negative correlation between Zn and dihomogammalinolenic acid concentration (r = −0.26; P < 0.05) was found in depressive inpatients. FA composition in serum significantly differed between depressive and healthy persons: Depressive patients had higher stearic and arachidonic acid (AA) concentration. Relative to AA, their eicosapentaenoic and docosapentaenoic acid concentration were diminished compared to the general populations group. These results do not confirm the hypothesis of a general lack of Zn in depressive disorders, but Zn concentrations differed dependent on comorbid disorders and severity of depression. In depressive patients and control persons Zn concentration is associated with different FAs indicating diverging metabolic pathways.
Similar content being viewed by others
Notes
The following fatty acids were measured (in brackets the abbreviations used in the text) 14:0(MYR); 16:0(PA); 16:1(PAI); 18:0(STE); 18:1n-9(OL); 18:2 n-6(LA); 18:3n-6(GLA); 18:3n-3(ALA); 20:3n-(DGLA); 20:4n-6(AA); 20:5n-3(EPA); 22:6n-3 (DHA).
Abbreviations
- AA:
-
Arachidonic acid 20:4n-6
- ALA:
-
Alphalinolenic acid 18:3n-3
- BDI:
-
Beck depression inventory
- DGLA:
-
Dihommogammalinolenic acid (20:3n-6)
- DHA:
-
Docosahexaenoic acid (22:6n-3)
- EPA:
-
Eicosapentaenoic acid (20:5n-3)
- FAs:
-
Fatty acids
- GLA:
-
Gammalinolenic acid (18:3n-6)
- HRSD:
-
Hamilton rating scale for depression
- LA:
-
Linoleic acid (18:2n-6)
- MYR:
-
Myristic acid (14:0)
- OL:
-
Oleic acid (18:1n-9)
- PAL:
-
Palmitic acid (16:0)
- PAI:
-
Palmitoleic acid (16:1n-7)
- PGE2:
-
Prostaglandin E2
- PUFA:
-
Polyunsaturated fatty acid
- STE:
-
Stearic acid (18:0)
- Zn:
-
Zinc
References
Lonergan PE, Martin DS, Horrobin DF et al (2004) Neuroprotective actions of eicosapentaenoic acid on lipopolysaccaride-induced dysfunction in rat hippocampus. J Neurochem 91:20–29
Song C, Leonard BE, Horrobin DF (2004) Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress 7:43–54
Severus WE, Ahrens B (2000) Omega-3 fatty acids in psychiatry. Nervenarzt 71:58–62. (Article in German)
Irmisch G, Schläfke D, Gierow W et al (2007) Fatty acids and sleep in depressed inpatients. Prostaglandins Leukot Essent Fat Acids 76:1–7
Ross BM, Seguin J, Sieswerda LE (2007) Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid? Lipids Health Dis 6:21
Freeman MP, Hibbeln JR, Wisner KL et al (2006) Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 67:1954–1967
Calderon F, Kim HY (2004) Docosahexaenoic acid promotes neurite growth in hippocampal neurons. J Neurochem 90:979–988
Bourre JM (2006) Effects of nutrients (in food) on the structure and function of the nervous system: update on dietary requirements for brain. Part 2: macronutrients. J Nutr Health Aging 10:386–399
Mackenzie GG, Zago MP, Aimo L et al (2007) Zinc deficiency in neuronal biology. IUBMB Life 59:299–307
Nowak G, Szewczyk B (2002) Mechanisms contributing to antidepressant zinc actions. Pol J Pharmacol 54:587–592
Marcellini F, Giuli C, Papa R et al (2006) Zinc status, psychological and nutritional assessment in old people recruited in five European countries: Zincage study. Biogerontology 7:339–345
Siwek MS, Wrobel A, Dudek D et al (2005) The role of zinc in the pathogenesis and treatment of affective disorders. [Article in Polish] Psychiatria polska 39:899–909
Levenson CW (2006) Zinc: the new antidepressant? Nutr Rev 64:39–42
Maes M, Mihaylova I, Leunis JC (2005) In chronic fatigue syndrome, the decreased levels of omega-3 poly-unsaturated fatty acids are related to lowered serum zinc and defects in T cell activation. Neuro Endocrinol Lett 26:745–751
Yousef MI, El-Hendy HA, El-Demerdash FM et al (2002) Dietary zinc deficiency induced-changes in the activity of enzymes and the levels of free radicals, lipids and protein electrophoretic behavior in growing rats. Toxicology 175:223–234
Irmisch G, Schläfke D, Richter J (2006) Relationships between fatty acids and psychophysiological parameters in depressive inpatients under experimentally induced stress. Prostaglandins Leukot Essent Fat Acids 74:149–156
Beck AT, Ward CH, Mendelson M et al (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Hamilton MA (1960) A rating scale for depression. J Clin Psychiatry 23:56–62
Maes M, Van-de-Vyvere J, Vandoolaeghe E et al (1996) Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process. J Affect Disord 40:23–33
Maes M, D’Haese PC, Scharpe S et al (1994) Hypozincemia in depression. J Affect Disord 31:135–140
Larsen MH, Mikkelsen JD, Hay-Schmidt A, Sandi C (2010) Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res, Feb 19 (Epub ahead of print)
Sowa-Kućma M, Legutko B, Szewczyk B, Novak K, Znojek P, Poleszak E, Papp M, Pilc A, Nowak G (2008) Antidepressant-like activity of zinc: further behavioral and molecular evidence. J Neural Transm 115:1621–1628
Maes M, Vandoolaeghe E, Neels H et al (1997) Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 42:349–358
Narang RL, Gupta KR, Narang AP, Singh R (1991) Levels of copper and zinc in depression. Indian J Physiol Pharmacol 35:272–274
Yazici KM, Akinci A, Sutcu A et al (2003) Bone mineral density in premenopausal women with major depressive disorder. Psychiatry Res 117:271–275
Battaglino R, Fu J, Späte U et al (2004) Serotonin regulates osteoclast differentiation through its transporter. J Bone Miner Res 19:1420–1431
Mollard RC, Weiler HA (2006) Dietary arachidonic acid and docosahexaenoic acid elevate femur calcium and reduce zinc content in piglets. Pediatr Res 60:418–422
Eder K, Kirchgessner M (1994) The effect of zinc deficiency on heart and brain lipids in rats force-fed with coconut oil or fish oil diets. Zeitschrift für Ernährungswissenschaft 33:136–145. (Article in German)
Tom Dieck H, Döring F, Fuchs D, Roth HP, Daniel H (2005) Transcriptome and proteome analysis identifies the pathways that increase hepatic lipid accumulation in zinc-deficient rats. J Nutr 135:199–205
Eder K, Kirchgessner M (1996) Zinc deficiency and the desaturation of linoleic acid in rats force-fed fat-free diets. Biol Trace Elem Res 54:173–183
Izumi Y, Auberson YP, Zorumski CF (2006) Zinc modulates bidirectional hippocampal plasticity by effects on NMDA receptors. J Neurosci 26:7181–7188
Hirzel K, Müller U, Latal AT et al (2006) Hyperekplexia phenotype of glycine receptor alpha1 subunit mutant mice identifies Zn (2+) as an essential endogenous modulator of glycinergic neurotransmission. Neuron 52:679–690
Chen BW, Wang HH, Liu JX, Liu XG (1999) Zinc sulphate solution enema decreases inflammation in experimental colitis in rats. J Gastroenterol Hepatol 14:1088–1092
Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G (2009) Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. J Affect Disord 118:187–195
Müller N (2010) COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. Curr Opin Investig Drugs 11:31–42
Conklin SM, Runyan CA, Leonard S, Reddy RD, Muldoon MF, Yao JK (2010) Age-related changes of n-3 and n-6 polyunsaturated fatty acids in the anterior cingulate cortex of individuals with major depressive disorder. Prostaglandins Leukot Essent Fat Acids 82:111–119
Yager S, Forlenza MJ, Miller GE (2010) Depression and oxidative damage to lipids. Psychoneuroendocrinology. Apr 21 (Epub ahead of print)
Lehto SM, Ruusunen A, Niskanen L, Tolmunen T, Voutilainen S, Viinamäki H, Kaplan GA, Kauhanen J (2010) Elevated depressive symptoms and compositional changes in LDL particles in middle-aged men. Eur J Epidemiol. Apr 23 (Epub ahead of print)
Khan FM, Kulaksizoglu B, Cilingiroglu M (2010) Depression and coronary heart disease. Curr Atheroscler Rep 12:105–109
Mozaffarian D, Micha R, Wallace S (2010) Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 23:e1000252
High KP, Sinclair J, Easter LH, Case D, Chilton FH (2003) Advanced age, but not anergy, is associated with altered serum polyunsaturated fatty acid levels. J Nutr Health Aging 7:378–384
Yanagisawa N, Shimada K, Miyazaki T, Kume A, Kitamura Y, Ichikawa R, Ohmura H, Kiyanagi T, Hiki M, Fukao K, Sumiyoshi K, Hirose K, Matsumori R, Takizawa H, Fujii K, Mokuno H, Inoue N, Daida H (2010) Polyunsaturated fatty acid levels of serum and red blood cells in apparently healthy Japanese subjects living in an urban area. J Atheroscler Thromb 17:285–294
Micallef M, Munro I, Phang M, Garg M (2009) Plasma n-3 polyunsaturated fatty acids are negatively associated with obesity. Br J Nutr 102:1370–1374
McNamara RK, Able J, Jandacek R, Rider T, Tso P (2009) Gender differences in rat erythrocyte and brain docosahexaenoic acid composition: role of ovarian hormones and dietary omega-3 fatty acid composition. Psychoneuroendocrinology 34:532–539
Laidlaw M, Holub BJ (2003) Effects of supplementation with fish oil-derived n-3 fatty acids and gamma-linolenic acid on circulating plasma lipids and fatty acid profiles in women. Am J Clin Nutr 77:37–42
Ghezzi S, Risé P, Ceruti S et al (2007) Effects of cigarette smoke on cell viability, linoleic acid metabolism and cholesterol synthesis, in THP-1 cells. Lipids 42:629–636
Szewczyk B, Poleszak E, Sowa-Kućma M, Siwek M, Dudek D, Ryszewska-Pokraśniewicz B, Radziwoń-Zaleska M, Opoka W, Czekaj J, Pilc A, Nowak G (2008) Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. Pharmacol Rep 60:588–599
Acknowledgments
The research project was supported by the German Research Foundation (DFG Er 225/2-1). There exists no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Irmisch, G., Schlaefke, D. & Richter, J. Zinc and Fatty Acids in Depression. Neurochem Res 35, 1376–1383 (2010). https://doi.org/10.1007/s11064-010-0194-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-010-0194-3